Hydrofarm Fails Nasdaq Equity Extension, Faces New Bid Price Deficiency — Requests Hearing to Stay Delisting
HYFM sits 15% above its 52-week low of $0.72.
Summary
Hydrofarm failed to meet Nasdaq's equity rule extension terms and received a new bid price deficiency notice. The company requested a hearing to stay delisting, but faces an uphill battle to regain compliance on both fronts.
Key Events · Legal and Risk Events · HYFM
-
Failed Equity Rule Extension
Nasdaq determined Hydrofarm did not meet the terms of its extension to regain compliance with the $2.5 million minimum stockholders' equity requirement, originally disclosed on April 1, 2026.
-
New Bid Price Deficiency
On July 6, 2026, Nasdaq notified the company it is non-compliant with the $1 minimum bid price rule, as the stock closed below $1 for 30 consecutive business days. The company has 180 days to regain compliance.
-
Hearing Request Stays Delisting
Hydrofarm timely requested a hearing before the Nasdaq Hearing Panel on July 9, 2026, which stays any delisting action pending the hearing and any extension granted by the panel.
-
Narrow Path to Compliance
With a stock price of $0.83 and a market cap of $3.95 million, the company faces significant challenges in meeting both the equity and bid price requirements. The filing states there is no assurance of success.
Analysis · HYFM · Trade & Services
A critical escalation has emerged for Hydrofarm Holdings Group: Nasdaq determined the company failed to meet the terms of its extension to regain compliance with the minimum stockholders' equity rule. At the same time, a new deficiency notice was issued for the $1 minimum bid price rule, as the stock has traded below $1 for 30 consecutive business days. To stay any delisting action, the company requested a hearing before the Nasdaq Hearing Panel, which pauses the process pending the hearing and any additional extension granted. This marks a sharp turn from the prior forbearance and extension news — the company is now actively fighting delisting on two fronts. With a market cap of only $3.95 million and a stock price of $0.83, the path to regaining compliance is narrow and uncertain. The hearing request buys time, but the company acknowledges there is no assurance of success. This filing materially increases the risk of a delisting event, which would severely impact liquidity and investor confidence.
At the time of this filing, HYFM was trading at $0.83 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $4M. The 52-week trading range was $0.72 to $4.78. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.